Vitamin K intake and status are low in hemodialysis patients

Kidney International

Volumn 82, Issue 5, 2012, Pages 605-610

  Cranenburg, Ellen C M ^a   Schurgers, Leon J ^b   Uiterwijk, Herma H ^c   Beulens, Joline W J ^d   Dalmeijer, Gerdien W ^d   Westerhuis, Ralf ^c   Magdeleyns, Elke J ^a   Herfs, Marjolein ^a   Vermeer, Cees ^a   Laverman, Gozewijn D ^c,e  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Dialysis Center Groningen   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

hemodialysis hazard; mineral metabolism; nutrition; target organ damage; vascular calcification

Indexed keywords

FARNOQUINONE; PHYTOMENADIONE;

ADULT; AGED; ARTERY CALCIFICATION; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; MALE; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VITAMIN INTAKE; VITAMIN K DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84865227042     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.191     Document Type: Article

References (27)

1. Vermeer C. Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase. Biochem J 1990; 266: 625-636. (Pubitemid 20103691)
2. Berkner KL, Runge KW. The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis. J Thromb Haemost 2004; 2: 2118-2132. (Pubitemid 40185771)
3. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483. (Pubitemid 30318271)
4. Raggi P, Boulay A, Chasan-Taber S et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002; 39: 695-701. (Pubitemid 34158168)
5. Blacher J, Guerin AP, Pannier B et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942. (Pubitemid 34258697)
6. London GM, Guerin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740. (Pubitemid 37098542)
7. Shroff RC, McNair R, Figg N et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008; 118: 1748-1757.
8. Beulens JW, van der AD, Grobbee DE et al. Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes. Diabetes Care 2010; 33: 1699-1705.
9. Krueger T, Westenfeld R, Ketteler M et al. Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification? Kidney Int 2009; 76: 18-22.
10. Maas AH, van der Schouw YT, Beijerinck D et al. Vitamin K intake and calcifications in breast arteries. Maturitas 2007; 56: 273-279.
11. Schurgers LJ, Vermeer C. Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis 2000; 30: 298-307. (Pubitemid 32453662)
12. Beulens JW, Bots ML, Atsma F et al. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis 2009; 203: 489-493.
13. Gast GC, de Roos NM, Sluijs I et al. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis 2009; 19: 504-510.
14. Geleijnse JM, Vermeer C, Grobbee DE et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004; 134: 3100-3105. (Pubitemid 39470091)
15. Cranenburg EC, Koos R, Schurgers LJ et al. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost 2010; 104: 811-822.
16. Beto JA, Bansal VK. Medical nutrition therapy in chronic kidney failure: integrating clinical practice guidelines. J Am Diet Assoc 2004; 104: 404-409. (Pubitemid 38296638)
17. Stein G, Sperschneider H, Koppe S. Vitamin levels in chronic renal failure and need for supplementation. Blood Purif 1985; 3: 52-62. (Pubitemid 16188876)
18. Cranenburg EC, Schurgers LJ, Vermeer C. Vitamin K: the coagulation vitamin that became omnipotent. Thromb Haemost 2007; 98: 120-125. (Pubitemid 47074186)
19. Spronk HM, Soute BA, Schurgers LJ et al. Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. J Vasc Res 2003; 40: 531-537. (Pubitemid 38186463)
20. Vermeer C, Shearer MJ, Zittermann A et al. Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health. Eur J Nutr 2004; 43: 325-335. (Pubitemid 40064268)
21. Schurgers LJ, Barreto DV, Barreto FC et al. The circulating inactive form of matrix Gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol 2010.
22. Pilkey RM, Morton AR, Boffa MB et al. Subclinical vitamin K deficiency in hemodialysis patients. Am J Kidney Dis 2007; 49: 432-439.
23. Urena P, De Vernejoul MC. Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int 1999; 55: 2141-2156. (Pubitemid 29256470)
24. Holden RM, Morton AR, Garland JS et al. Vitamins K and D status in stages 3-5 chronic kidney disease. Clin J Am Soc Nephrol 2010; 5: 590-597.
25. Schurgers LJ, Teunissen KJ, Hamulyak K et al. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 2007; 109: 3279-3283. (Pubitemid 46572513)
26. Westenfeld R, Krueger T, Schlieper G et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis 2012; 59: 186-195.
27. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997; 65: 1220S-1228S. (Pubitemid 27152591)